Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06830109 · ClinicalTrials.gov registry record · Phase 2

Nasal Obstruction With Oxymetazoline and Corticosteroids

A Phase 2 study of Nasal Obstruction, sponsored by Washington University School of Medicine.

Recruiting
Registry status
Phase 2
Development phase
80
Enrollment target
1
Study location

NCT06830109 is a Phase 2 study of Nasal Obstruction that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 80 participants, below the 146-participant average among 4 other Nasal Obstruction trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06830109, a Phase 2 study of Nasal Obstruction, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
Phase 2
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine the efficacy and safety of commination oxymetazoline/intranasal steroids for long-term management of chronic nasal obstruction that is recalcitrant to the current standard of care. The investigators hypothesize that combination treatment with oxymetazoline and intranasal corticosteroid spray will provide a larger reduction in nasal obstruction than intranasal corticosteroid alone for patients suffering from chronic nasal obstruction, and there will not be occurrences of rhinitis medicamentosa.

Conditions Studied

Interventions

  • DRUG Budesonide nasal spray
  • DRUG Oxymetazoline Nasal Spray

Study Locations (1)

Missouri

  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-10-15
Est. Completion 2026-12-30
Phase Phase 2

What the Registry Record Tells You About NCT06830109

The ClinicalTrials.gov registry entry for NCT06830109 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 146-participant average among 4 other Nasal Obstruction trials with a reported enrollment target (45% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nasal Obstruction appearing as the primary indexed condition, and to 2 interventions - of which Budesonide nasal spray is the first listed.

NCT06830109 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06830109 about?

NCT06830109 is a clinical study titled "Nasal Obstruction With Oxymetazoline and Corticosteroids". This study aims to examine the efficacy and safety of commination oxymetazoline/intranasal steroids for long-term management of chronic nasal obstruction that is recalcitrant to the current standard of care. The investigators hypothesize that combination treatment with oxymetazoline and intranasal c...

What is the current status of trial NCT06830109?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2024-10-15. Estimated completion is 2026-12-30.

What conditions does trial NCT06830109 study?

This clinical trial studies the following conditions: Nasal Obstruction.

What interventions are being tested in trial NCT06830109?

The interventions under investigation include: Budesonide nasal spray (DRUG), Oxymetazoline Nasal Spray (DRUG).

Who is sponsoring clinical trial NCT06830109?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06830109 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nasal Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.